Flúter auricular paroxístico asociado a zoledronato: ¿un nuevo efecto adverso?

Black, 2007, Once yearly zoledronic acid for treatment of postmenopausal osteoporosis, N Engl J Med, 356, 1809, 10.1056/NEJMoa067312 Lyles, 2007, Zoledronic Acid and clinical fractures and mortality after hip fracture, N Engl J Med, 357, 1799, 10.1056/NEJMoa074941 Cummings, 2007, Alendronate and atrial fibrilation, N Engl J Med, 356, 1895, 10.1056/NEJMc076132 Black, 1996, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, Lancet, 348, 1535, 10.1016/S0140-6736(96)07088-2 Cummings, 1998, Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial, JAMA, 280, 2077, 10.1001/jama.280.24.2077 Heckbert, 2008, Use of alendronato and risk of incident atrial fibrillation in women, Arch Intern Med, 168, 826, 10.1001/archinte.168.8.826 Sorensen, 2008, Use of biphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study, BMJ, 336, 813, 10.1136/bmj.39507.551644.BE Dicuonzo, 2003, Fever after zoledronic acid administration is due to increase in TNF alpha and IL-6, J Interferon Cytokine Res, 23, 649, 10.1089/107999003322558782